Objectives
The CBP team was contracted to assess the unmet needs across the cystic fibrosis treatment modalities and their associated commercial opportunity as well as any cannibalization potential within their current CF portfolio.
Scope
Methodology
Conduct qualitative research with 14 key opinion leaders (KOLs) and 5 specialists in the CF space; respondents were split into 2 different groups, each covering 2 cystic fibrosis (CF) modalities, and asked to identify unmet needs, rate current treatment satisfaction and design a breakthrough therapy in a pre-survey.
Deliverables
- Pipeline scan across each treatment modality
- A prioritization of investment opportunities based on their commercial potential as well as long-term fit with the client’s portfolio
Illustrative Outputs
Impact
CBPartners leveraged expert KOL opinion to help formalize a client’s cystic fibrosis investment strategy.